Who's Who

Who's Who in Malta's Medical Cannabis Sector

With the European medical cannabis market forecast to reach a value in excess of EUR 55 billion within the next decade, Malta has been quick out of the starting blocks to position itself as the first EU Member State to provide a holistic regulatory framework for this category of rapidly emerging therapies.

The island’s landmark 2018 legislation for industrial scale production and export has already served to entice in as many as 26 heavyweight, big brand cannabinoid-based pharma MNCs. 

Many believe that establishing a foothold in this niche will not only trigger a second coming of the local pharmaceutical sector, but deliver much needed shot in the arm for the island’s agro-industry as well. New capital investments have already been placed to the tune of EUR 150 million and the authorities are predicting employment creation of around 1,000 full time jobs within the next 3 years, not to mention growth of auxiliary industries right along the value chain that can service and supply. Moreover, medical cannabis is now projected to contribute EUR 1 billion worth of new exports by 2022.

 


 

Want to Know More

Find out more about the upcoming edition of the CountryProfiler Malta Report, the most influential publication on doing business and investing in Malta. To participate in this report, contact Garvan Keating on +356 99252229 or keating@countryprofiler.com.








MaltaProfile has listed the companies operating in the medical cannabis space: 


MGC Pharma

MPXI Malta 

Emmac Life Sciences

Panaxia

The Pain Clinic

Mera Cannabis 

Aphria

Columbia Care 

Labopharm 

ZenPharm 

CBD Intel 

Cobidol 

Supreme

Materia 

PT Matic Environmental Services 

SIGN UP TO AND RECEIVE OUR NEWSLETTER

Brands who work with us